Spire Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Spire Wealth Management's BSX Position: Q2 2026 in Review
Spire Wealth Management reduced its Boston Scientific (BSX) stake by 76% in Q2 2026, selling an estimated $342K and leaving 2,012 shares worth $85.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.
Spire Wealth Management first reported a position in BSX in Q1 2021 and has held it in 22 quarters since. The position peaked at $2.25M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Spire Wealth Management held 2,012 shares of Boston Scientific worth $85.9K as of Q2 2026.
- Spire Wealth Management sold 6,301 Boston Scientific shares in Q2 2026, an estimated $342K.
- Boston Scientific made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1018 holding.
- Spire Wealth Management first reported a position in Boston Scientific in Q1 2021 and has held it in 22 quarters since.
- Spire Wealth Management's Boston Scientific position peaked at $2.25M in Q3 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.